SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001438533-20-000026
Filing Date
2020-10-22
Accepted
2020-10-22 16:05:20
Documents
16
Period of Report
2020-10-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rtrx-20201021.htm   iXBRL 8-K 48758
2 EX-99.1 ex10-22x2020991.htm EX-99.1 20684
8 image11.jpg GRAPHIC 7627
  Complete submission text file 0001438533-20-000026.txt   236554

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20201021.xsd EX-101.SCH 2523
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20201021_cal.xml EX-101.CAL 805
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20201021_def.xml EX-101.DEF 1769
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20201021_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20201021_pre.xml EX-101.PRE 13285
9 EXTRACTED XBRL INSTANCE DOCUMENT rtrx-20201021_htm.xml XML 10967
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 201254988
SIC: 2834 Pharmaceutical Preparations